LONDON — European markets showed signs of recovery on Tuesday, rebounding from losses in the previous trading session. The Stoxx 600, a key index across the continent, climbed 0.2% by mid-morning, reaching a new peak of 588.42 points shortly after the market opened. This marks a significant increase of 14% for the year, positioning the index for potential consecutive annual gains for the third time.

Investor attention is particularly focused on Novo Nordisk, which recently secured U.S. Food and Drug Administration (FDA) approval for the first GLP-1 medication in pill form. This development provides the Danish pharmaceutical firm with a competitive edge over its American competitor, Eli Lilly. Following the announcement, shares of Novo Nordisk surged approximately 7.5%.

In a parallel move, Zealand Pharma, another player in the health sector, experienced a share price increase of 2.3%. European biotech company Abivax also continued its upward trend, adding 1.4% to its stock price after an impressive performance on Monday, when it grew by over 15%.

On a less fortunate note, Danish renewable energy company Ørsted saw its shares drop by 13% following news that the U.S. Department of the Interior had paused leases on five offshore wind projects currently in construction. Although Ørsted successfully contested a previous halt order on its Revolution Wind project earlier this year, its stock reflected investor concerns amid these developments, declining 0.9% in early trading.

Meanwhile, Greenland’s Prime Minister Jens-Frederik Nielsen dismissed recent efforts by U.S. officials to appoint a special envoy to the territory. The move has sparked discussions related to President Trump’s past interest in acquiring Greenland, driven by its significant rare earth minerals.

On the economic front, final GDP data from Spain is anticipated on Tuesday, with earlier provisional figures indicating a year-on-year growth of 2.8%. This data may provide critical insights into the health of the Spanish economy amidst the broader European context.

In the Asia-Pacific region, markets opened mostly higher, buoyed by optimism in U.S. trading, where major indexes performed strongly. In the United States, stock futures were stable following a positive start to a shortened trading week.

These market movements underscore the varied dynamics shaping the European and global financial landscapes as investors navigate both opportunities and challenges in the lead-up to year-end.